Dr. Rohit S. Satoskar, MD

Dr. Satoskar practices at Medstar Georgetown Medical Center in Washington, District of Columbia.

Dr. Satoskar's NPI, 1962447607, was assigned on June 17, 2006. Dr. Satoskar graduated from Medical College of Ohio in 2000. Dr. Satoskar holds District of Columbia license MD038193.

Dr. Satoskar's primary practice is Medstar Georgetown Medical Center, at 3800 Reservoir NW Rd, Washington, DC 20007 in District Of Columbia County. The practice phone is (202) 444-1400.

Dr. Satoskar's primary practice is Medstar Georgetown Medical Center in Washington, District of Columbia. Dr. Satoskar is also affiliated with MedStar Georgetown University Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Satoskar to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Satoskar practices, 2 sites in all. Vendor and product names are available with a free account.

Transplant hepatology is Dr. Satoskar's primary specialty in the NPI Registry, under taxonomy code 207RT0003X. Dr. Satoskar is licensed in District of Columbia.

CMS data shows 337 Medicare services from Dr. Satoskar across 7 procedure codes in 2024, for 215 Medicare patients. Medicare paid $45,517 for them.

CMS counts 215 Medicare patients who saw Dr. Satoskar in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Satoskar's median patient age at 59, with 49% women.

In 2024, Dr. Satoskar wrote 339 Medicare Part D claims for 69 patients. 87% of them were for generic drugs. CMS names the drug for 226 of them, across 11 drugs with 11 or more claims each, at $136,432 in total drug cost. In 2023, CMS named 211 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Satoskar for performance year 2024, reported as part of a group. Dr. Satoskar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Satoskar as offering telehealth. CMS counts 25 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Satoskar, more than 53% of the clinicians it reports for that procedure.

Dmand AI links 26 papers to Dr. Satoskar, published from 2010 to 2022. 2013 was the busiest year, with 4. The most frequent topics are Liver Transplantation, Hepacivirus and Antiviral Agents. Dr. Satoskar has published most often in Clin Transplant. Dr. Satoskar's most frequent co-authors are Thomas Fishbein, MD, Nancy S. Reau, MD and Thomas D. Schiano, MD.

Dmand AI links Dr. Satoskar to 2 clinical trials. Conditions studied include Hepatitis C and Flaviviridae Infections.

CMS Open Payments shows 118 general payments to Dr. Satoskar from 7 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Gilead Sciences, Inc. paid the most, $59,661.

Dr. Satoskar graduated from Medical College of Ohio in 2000.